PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS

First Page		Document Content
Coagulation Octapharma Factor X Thrombogenicity Thrombin Coagulation system Blood Anatomy		PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 226,69 KB Share Document on Facebook